PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
T. matsutake-derived peptides (SDLKHFPF and SDIKHFPF) significantly attenuated gastric mucosal injury, reduced the ulcer index, and inhibited GES-1 cell apoptosis in mice [PMID:34866395].
Functional cookies fortified with T. matsutake powder significantly prolonged exhaustive swimming time in mice, increased muscle and liver glycogen, and reduced serum lactic acid and urea nitrogen [PMID:33159467].
T. matsutake extracts promoted the proliferation of human immortalized keratinocyte (HaCaT) cells and accelerated wound healing in mice [PMID:34591397].
Evidence summary
PubMed sources
- 1.PMID: 37495313 (2023) — Fungal volatiles have physiological properties. · Fungal biology
- 2.PMID: 34985354 (2023) — Insights into health promoting effects and myochemical profiles of pine mushroom Tricholoma matsutake. · Critical reviews in food science and nutrition
- 3.PMID: 29858828 (2018) — Root-associated bacteria influencing mycelial growth of Tricholoma matsutake (pine mushroom). · Journal of microbiology (Seoul, Korea)
- 4.PMID: 37929006 (2023) — Promotion of Tricholoma matsutake mycelium growth by Penicillium citreonigrum. · Mycobiology
- 5.PMID: 37133359 (2023) — Draft Genome Sequence for the Symbiotic Pine Mushroom Tricholoma matsutake.